Core binding factor acute myeloid leukemia
MONDO:0850269An acute myeloid leukemia that is characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities result in disruption of the transcription factor CBF, which is a regulator of normal hematopoiesis.
3085 clinical trials for this condition and its sub-types, 5 tagged with Core binding factor acute myeloid leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of